Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health
Obstetrics & Gynecology Science
; : 125-132, 2022.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-938915
Responsible library:
WPRO
ABSTRACT
Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
English
Journal:
Obstetrics & Gynecology Science
Year:
2022
Document type:
Article